2019
Investigation of Preanalytical Variables Impacting Pathogen Cell-Free DNA in Blood and Urine
Murugesan K, Hogan C, Palmer Z, Reeve B, Theron G, Andama A, Somoskovi A, Steadman A, Madan D, Andrews J, Croda J, Sahoo M, Cattamanchi A, Pinsky B, Banaei N. Investigation of Preanalytical Variables Impacting Pathogen Cell-Free DNA in Blood and Urine. Journal Of Clinical Microbiology 2019, 57: 10.1128/jcm.00782-19. PMID: 31511335, PMCID: PMC6813001, DOI: 10.1128/jcm.00782-19.Peer-Reviewed Original ResearchConceptsEpstein-Barr virusCell-free DNABlood collection tubesUrine samplesLower medianPCR cycle thresholdCollection tubesEDTA blood samplesTB patientsTuberculosis patientsUrine volumeHealthy donorsBlood samplesAttractive biomarkerEDTA tubesPatient samplesBloodWhole urineThawed plasmaUrineUrine preservativeCycle thresholdMedianPatientsPreanalytical factors
2016
Factors associated with anti-TB drug-induced hepatotoxicity and genetic polymorphisms in indigenous and non-indigenous populations in Brazil
Heinrich M, Zembrzuski V, Ota M, Sacchi F, Teixeira R, Acero P, Cunha G, Souza-Santos R, Croda J, Basta P. Factors associated with anti-TB drug-induced hepatotoxicity and genetic polymorphisms in indigenous and non-indigenous populations in Brazil. Tuberculosis 2016, 101: 15-24. PMID: 27865386, DOI: 10.1016/j.tube.2016.07.006.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overAntitubercular AgentsArylamine N-AcetyltransferaseBrazilChemical and Drug Induced Liver InjuryChildChild, PreschoolCross-Sectional StudiesCytochrome P-450 CYP2E1FemaleGenetic Predisposition to DiseaseGenotypeGlutathione TransferaseHumansIncidenceInfantLongitudinal StudiesMaleMiddle AgedPolymorphism, Single NucleotideTuberculosis, PulmonaryYoung AdultConceptsIncidence of hepatotoxicityAdverse drug reactionsIndigenous patientsAnti-TB drug-induced hepatotoxicityNon-conditional logistic regressionClinical-epidemiological factorsClinical-epidemiological variablesNon-Indigenous patientsGenetic polymorphismsRisk of hepatotoxicityDrug-induced hepatotoxicityPolymorphisms of CYP2E1Anti-tuberculosis drugsAcetylation profileTB patientsSerum levelsDrug reactionsGSTM1 polymorphismOdds ratioLiver enzymesNon-Indigenous populationsTherapeutic schemesPharmacogenetic analysisBetter outcomesPatients
2014
Health-service performance of TB treatment for indigenous and non-indigenous populations in Brazil: a cross-sectional study
Lemos E, Alves A, Oliveira G, Rodrigues M, Martins N, Croda J. Health-service performance of TB treatment for indigenous and non-indigenous populations in Brazil: a cross-sectional study. BMC Health Services Research 2014, 14: 237. PMID: 24885134, PMCID: PMC4049501, DOI: 10.1186/1472-6963-14-237.Peer-Reviewed Original ResearchConceptsNon-Indigenous populationsTB diagnosisPrimary Care Assessment ToolNon-Indigenous patientsCare Assessment ToolCross-sectional studyHealth service performanceTB patientsMost patientsSymptom onsetTB careTB treatmentTuberculosis controlTreatment strategiesMedical appointmentsHome visitsFirst treatmentHealth professionalsHealth servicesPatientsDiagnosisHealthcare qualityTreatmentSocial supportAssessment tool
2012
Tuberculosis control in a highly endemic indigenous community in Brazil
Croda M, Trajber Z, da Costa Lima R, Croda J. Tuberculosis control in a highly endemic indigenous community in Brazil. Transactions Of The Royal Society Of Tropical Medicine And Hygiene 2012, 106: 223-229. PMID: 22365154, DOI: 10.1016/j.trstmh.2012.01.005.Peer-Reviewed Original ResearchConceptsTB treatmentNon-Indigenous populationsTB patientsTB case fatality rateImplementation of DOTSRetrospective cohort studyCase fatality rateNumber of patientsHIV-positive statusTimes higher mortalityHigh rateCohort studyTB controlCase fatalityDOTS implementationHIV prevalenceTuberculosis controlFatality rateHigh mortalityMultivariate analysisPatientsYoung adultsMortalityPriority groupsIndigenous populations